מינון ומתן של נוגדנים חד–ספציפיים ודו–ספציפיים נגד 1r–igf נגד erbb3
- 专利权人:
- MERRIMACK PHARMACEUTICALS INC.
- 发明人:
- 申请号：
- IL23486614
- 公开号：
- IL234866D0
- 申请日:
- 2014.09.29
- 申请国别(地区):
- IL
- 年份:
- 2014
- 代理人:
- 摘要：
- Provided are methods for the administration of therapeutic bispecific anti-IGF-1R and anti-ErbB3 antibodies, either alone or in combination with other anti-cancer therapeutics.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Dosage and administration of monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies
- DOSAGE ET ADMINISTRATION D'ANTICORPS ANTI-IGF-1R ET ANTI-ERBB3 MONOSPECIFIQUES ET BISPECIFIQUES
- COMBINATION ANTIBODY AGAINST THE OX40 AND THE TLR4 MODULATOR AND THEIR APPLICATION
- COMPOSITIONS COMPRISING A P75 TUMOR NECROSIS FACTOR RECEPTOR/IG FUSION PROTEIN
- Method for treating Th17 inflammatory diseases by inhibiting vascular endothelial growth factor receptor, and pharmaceutical composition for the same
